Skip to content
NHQualityCampaign.orgIndependent nursing home quality resource
Dementia CareFor families & professionals

Dementia Care in Nursing Homes: A Guide for Families and Staff

Good dementia care in a nursing home means knowing the person, treating causes of distress, and using antipsychotics only as a last resort. CMS reports long-stay antipsychotic use fell from 23.9% in 2011 to 14.2% in 2025. This guide explains what good care looks like, why antipsychotic drugs carry an FDA boxed warning for people with dementia, which non-drug approaches have evidence behind them, and what families and professionals each need to do.

Updated 9 min readHow we research
Nurse smiling and talking with an older woman in her care
Photo: Age Cymru (Unsplash License). Credits

What does good dementia care in a nursing home look like?

Many long-stay nursing home residents live with Alzheimer disease or another dementia, and their care depends less on any single drug than on daily routines, relationships and how staff respond when someone is distressed. Federal rules require nursing homes to give residents with dementia the "appropriate treatment and services to attain or maintain" their highest practicable well-being (42 CFR 483.40(b)(3), surveyed as F744). In practice, good care has five visible features:

  1. Staff know the person. Life history, routines, preferences, what calms them and what upsets them are written down and used. This is the core of person-centered care.
  2. The same caregivers show up. Consistent assignment lets aides notice small changes early and builds trust that reduces distress during bathing, dressing and toileting.
  3. Distress is treated as a message. When someone shouts, resists care or wanders, staff look for pain, infection, delirium, hunger, constipation, boredom or noise before anyone reaches for a drug.
  4. Days have meaning. Structured, individualized activities, time outdoors, music the person loves and chances to help with simple tasks.
  5. Medications are reviewed, not just renewed. Antipsychotics and other psychotropics have a documented reason, a target symptom, monitoring and regular attempts at gradual dose reduction.

Why are antipsychotics risky for people with dementia?

In April 2005 the US Food and Drug Administration asked makers of atypical (second-generation) antipsychotics such as risperidone, olanzapine, quetiapine and aripiprazole to add a boxed warning: elderly patients with dementia-related psychosis treated with these drugs have an increased risk of death. In June 2008 the FDA extended the warning to conventional antipsychotics such as haloperidol. The labels also state that these drugs are not approved for dementia-related psychosis.

The evidence behind the warning is consistent. A 2005 JAMA meta-analysis of 15 short placebo-controlled trials found deaths in 3.5% of people given an atypical antipsychotic versus 2.3% on placebo. A 2015 JAMA Psychiatry study of US veterans with dementia estimated one additional death for roughly every 26 people treated with haloperidol, 27 with risperidone, 40 with olanzapine and 50 with quetiapine over about six months. Other recognized harms include stroke, falls and fractures, pneumonia, sedation, parkinsonism and faster functional decline.

That does not mean antipsychotics are never appropriate. When a resident has frightening psychosis or aggression that puts them or others in danger, and other approaches have failed, a time-limited trial with clear target symptoms may be reasonable. Our page on reducing antipsychotic use explains the evidence, the regulations and how dose reduction works.

How far has antipsychotic use fallen in US nursing homes?

23.9%
Long-stay residents on an antipsychotic, Q4 2011 (baseline)
Source: CMS
14.2%
Same measure, Q2 2025
Source: CMS data report
40.6%
Relative reduction since 2011
Source: CMS data report

These figures come from CMS's long-stay quality measure, which counts residents receiving an antipsychotic but excludes those with schizophrenia, Huntington disease or Tourette syndrome. In January 2026 CMS replaced it with a "hybrid" version that adds Medicare and Medicaid claims and Medicare Advantage encounter data. CMS projected the national rate would read about 16.98% under the new method versus 14.64% under the old one, because claims catch prescriptions the MDS missed. A higher number on Care Compare in 2026 is therefore not by itself a sign that care got worse. See long-stay quality measures for how the measure is calculated.

What was the National Partnership to Improve Dementia Care?

CMS announced the National Partnership to Improve Dementia Care in Nursing Homes on May 30, 2012, with federal and state agencies, nursing homes, professional associations, advocates and families. Its first target was a 15% cut in long-stay antipsychotic use; later goals were 25% by the end of 2015 and 30% by the end of 2016, which CMS reported was met. Archived pages show the original Advancing Excellence campaign, which used this domain until about 2018, offered tools to help nursing homes meet the Partnership's goals. This site is independent and not affiliated with either. Read the full history on our National Partnership page.

What are responsive behaviors, and what causes them?

"Responsive behaviors" (often called behavioral and psychological symptoms of dementia, or BPSD) include agitation, calling out, resisting care, wandering, sleep reversal, suspiciousness, hallucinations and apathy. The term reflects a simple idea: the behavior is usually a response to something. Common triggers:

Common causes of distress in people with dementia
CategoryExamplesWhat staff can check
PhysicalPain, constipation, urinary retention, infection, dehydration, hunger, poor hearing or visionPain scale, bowel record, vitals, hydration, glasses and hearing aids
Acute illnessDelirium from infection, new drugs, low oxygen or low sodiumSudden change from baseline, confusion that fluctuates over hours
MedicationAnticholinergics, sedatives, opioids, recent dose changesPharmacist review of every drug started or changed recently
EnvironmentNoise, glare, crowded rooms, unfamiliar staff, shift changeWhen and where the behavior happens
Care approachRushed bathing, being approached from behind, complex instructionsWho was present and what task was underway
Unmet psychosocial needsBoredom, loneliness, fear, loss of purposeLife history, preferred activities, family input

Our guide to behavioral symptoms of dementia covers assessment, delirium versus dementia, and when medication may be considered.

Which non-drug approaches work best?

The best-supported non-drug approaches are systematic, not one-off activities. Four with solid research behind them:

  • The DICE approach (Describe, Investigate, Create, Evaluate), recommended by a multidisciplinary expert panel in 2014, gives teams a step-by-step way to find triggers and design a plan.
  • Treating pain. In a 2011 Norwegian cluster trial, a stepwise pain protocol (mostly scheduled acetaminophen) cut agitation scores by about 17% over eight weeks.
  • Staff training plus antipsychotic review. The UK WHELD trial in 69 nursing homes improved quality of life and reduced agitation with person-centered care training, social interaction and medication review.
  • Individualized activity and routine. Music, reminiscence, exercise and sleep hygiene help some people; benefit depends on tailoring and staff follow-through.

Not every popular program has strong trial results. A large 2022 US trial of personalized music playlists in 54 nursing homes found no overall reduction in agitation or psychotropic use, although many residents enjoy it. Details are on our non-drug approaches page.

What do the federal rules require?

Key federal requirements for dementia care and psychotropic drugs (as of 2026)
RequirementRegulation / F-tagWhat it means
Dementia treatment and services483.40(b)(3), F744Individualized, person-centered dementia care to reach the highest practicable well-being
Psychotropic drugs and chemical restraints483.45(c)(3), (d), (e); 483.10(e)(1), 483.12(a)(2); F605Specific documented diagnosis, gradual dose reductions, behavioral interventions, 14-day PRN limits; no drugs for staff convenience or discipline
Informed consent483.10(c), F552Resident or representative told of benefits, risks (including boxed warnings) and alternatives before a psychotropic is started or increased
Unnecessary non-psychotropic drugs483.45(d), F757No excessive dose or duration, adequate monitoring and indication
Dementia training483.95(c), F943; 483.95(g), F947Dementia management in abuse-prevention training; at least 12 hours per year of nurse aide in-service including dementia care
Medical director oversight483.70, F841Medical director expected to address inappropriate psychotropic prescribing

CMS folded the old F758 psychotropic tag into F605 (chemical restraints) in revised surveyor guidance that took effect on April 28, 2025. A psychotropic given without adequate documentation of indication, non-drug attempts and dose-reduction efforts can now be cited as a chemical restraint, a resident rights and abuse-prevention deficiency.

What do families need to know?

  • You have the right to be told why a psychotropic is proposed, its risks (including the boxed warning) and alternatives, and to say no.
  • Ask what target symptom a drug is treating, how improvement will be measured, and when a dose reduction will be tried.
  • Share your relative's history, routines and comforts. Staff use it to prevent distress.
  • Attend care plan meetings and ask for behaviors to be described, not labeled.
  • If concerns go unanswered, the long-term care ombudsman can help at no cost.

Our guide for families includes a printable question list, memory care versus nursing home comparisons and visiting tips.

What do professionals need to have in place?

  1. 1
    Know the person
    Complete a life-history and preferences profile within the first week and put it in the care plan.
  2. 2
    Standardize behavior assessment
    Use DICE or a similar structured tool, a pain scale for non-verbal residents and a delirium screen whenever behavior changes.
  3. 3
    Make psychotropic review routine
    Monthly pharmacist review, documented target symptoms, consent, and gradual dose reduction attempts in two separate quarters in the first year unless contraindicated.
  4. 4
    Train and huddle
    Meet F947 dementia training requirements and use daily huddles to share what worked for each resident.
  5. 5
    Track and improve
    Trend your antipsychotic rate under the 2026 hybrid measure and run it through QAPI.

The professional toolkit page covers training content, care planning for behaviors, audit tools and huddle scripts.

In this guide

Frequently asked questions

Why are antipsychotics dangerous for people with dementia?

Antipsychotics carry an FDA boxed warning because older adults with dementia-related psychosis who take them have a higher risk of death, mostly from heart problems and infections such as pneumonia. They also raise the risk of stroke, falls, sedation and loss of function. They may still be used when symptoms are dangerous and other approaches have failed, with consent and close monitoring.

What is person-centered dementia care?

Person-centered dementia care organizes daily care around the individual rather than the facility schedule. Staff learn the person's history, routines, preferences and what calms them, and they use that knowledge to plan bathing, meals, activities and responses to distress. It is supported by federal nursing home rules and by trials showing better quality of life and less agitation.

Can a nursing home give my parent an antipsychotic without permission?

Under federal surveyor guidance in effect since 2025, the resident or their representative must be told the benefits, risks (including boxed warnings) and alternatives before a psychotropic is started or the dose is increased, and has the right to decline. A facility that skips this can be cited under F552. Some states require written consent. Emergencies are handled under state law.

What percentage of nursing home residents are on antipsychotics?

CMS reports that 14.2% of long-stay residents received an antipsychotic in the second quarter of 2025 under its older MDS-based measure, which excludes schizophrenia, Huntington disease and Tourette syndrome. That compares with 23.9% at the end of 2011. CMS's updated 2026 measure adds claims data and was projected to show about 17% nationally.

What are the best non-drug treatments for dementia agitation?

The best-supported approaches are structured: finding and treating triggers with a method such as DICE, treating pain, consistent caregivers, staff training in person-centered care, individualized activities, good sleep routines and calmer environments. Trials show modest but real reductions in agitation. Programs work best when staff are trained and supported to deliver them every day.

What causes sudden behavior changes in someone with dementia?

A sudden change often signals a medical problem rather than progression of dementia. Common causes include delirium from a urinary or chest infection, pain, constipation, dehydration, a new or changed medication, low oxygen or poor sleep. Any sudden change in alertness, attention or behavior should prompt a prompt medical assessment.

Free, no-obligation help

Get help choosing care or coverage

Talk with a licensed agent about Medicare, Medigap, Medicare Advantage and ways to pay for a nursing home stay. Or call 1-800-MEDIGAP (1-800-633-4427).

Answered by licensed insurance agents, not by Medicare or CMS.

Sources

  1. CMS: Antipsychotic Medication Use Data Report (2025 Q2 data)
  2. CMS: National Partnership to Improve Dementia Care in Nursing Homes
  3. Schneider LS et al. Risk of death with atypical antipsychotics for dementia: meta-analysis. JAMA 2005
  4. Maust DT et al. Antipsychotics and risk of death in dementia: number needed to harm. JAMA Psychiatry 2015
  5. 42 CFR 483.45: Pharmacy services, unnecessary and psychotropic drugs
  6. CMS QSO-25-20-NH (revised Sept 2025): Updated long-stay antipsychotic measure

Medical disclaimer. This page is general education, not medical, legal or financial advice, and it does not replace the judgment of a qualified clinician who knows the resident. Do not start, stop or change any medication without talking to the prescriber. In an emergency, call 911.

Independent resource. NHQualityCampaign.org is an independent educational resource. It is not affiliated with, endorsed by or operated by the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services (HHS), any government agency, or the original Advancing Excellence in America’s Nursing Homes campaign or its sponsors. Historical campaign information is summarized with attribution for educational purposes.